` Comparison: 9214 vs CVS - Alpha Spread

R
9214
vs
CVS

Over the past 12 months, Recovery International Co Ltd has underperformed CVS, delivering a return of +8% compared to the CVS's +10% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
9214
CVS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Recovery International Co Ltd Intrinsic Value
HIDDEN
Show
CVS Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
R
Recovery International Co Ltd
TSE:9214
1 469 JPY
CVS Health Corp
NYSE:CVS
74.81 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
9214, CVS

9214
CVS
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
R
Recovery International Co Ltd
Revenue
CVS Health Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
9214, CVS

9214
CVS
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
R
Recovery International Co Ltd
TSE:9214
CVS Health Corp
NYSE:CVS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Recovery International Co Ltd
43.2%
CVS
13.8%

Operating Margin

Recovery International Co Ltd
7.8%
CVS
2.6%

Net Margin

Recovery International Co Ltd
5.1%
CVS
0.4%

FCF Margin

Recovery International Co Ltd
2.7%
CVS
1.9%

ROE

Recovery International Co Ltd
22.8%
CVS
2.3%

ROA

Recovery International Co Ltd
12.9%
CVS
0.7%

ROIC

Recovery International Co Ltd
23.3%
CVS
4.6%

ROCE

Recovery International Co Ltd
30.1%
CVS
6.3%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
9214, CVS

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
9214, CVS

Performance Gap Between 9214 and CVS
HIDDEN
Show

Performance By Year
9214, CVS

Loading
9214
CVS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 9214 to other stocks
CGN
Cigna Group
C
More expensive
vs Recovery International Co Ltd
CI
Cigna Corp
More expensive
vs Recovery International Co Ltd
FRE
Fresenius SE & Co KGaA
More expensive
vs Recovery International Co Ltd
FME
Fresenius Medical Care AG
More expensive
vs Recovery International Co Ltd
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett